SIV CARDIOMYOPATHY: PATHOGENESIS AND PREVENTION
SIV 心肌病:发病机制和预防
基本信息
- 批准号:7715431
- 负责人:
- 金额:$ 23.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-06-05 至 2009-04-30
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeCardiacCardiomyopathiesCardiovascular systemChronicComputer Retrieval of Information on Scientific Projects DatabaseCuriositiesFundingGrantHIVHIV InfectionsHeart DiseasesHighly Active Antiretroviral TherapyIndividualInstitutionLifeMorbidity - disease ratePathogenesisPathologicPathologyPatientsPredispositionPreventionResearchResearch PersonnelResourcesRisk FactorsSourceUnited States National Institutes of Health
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
HIV associated cardiac pathology is being recognized increasingly as patients with chronic HIV infection survives to live productive lives. HIV associated cardiomyopathy is among the most common cardiac specific manifestation of chronic HIV infection and was observed in between 6-12% of patients that succumb to AIDS. However, cardiovascular involvement has emerges as more than a pathologic curiosity, but rather as a significant cause of morbidity as individuals live longer, more productive lives with HIV. Increased use of HAART therapy has served to unmask HIV associated predispositions to cardiac involvement. Despite the increased recognition, the risks factors for, the pathogenesis of, and the specific treatments required in HIV associated cardiac disease remain unknown.
这个子项目是许多研究子项目中的一个
由NIH/NCRR资助的中心赠款提供的资源。子项目和
研究者(PI)可能从另一个NIH来源获得了主要资金,
因此可以在其他CRISP条目中表示。所列机构为
研究中心,而研究中心不一定是研究者所在的机构。
随着慢性艾滋病毒感染患者的生存,艾滋病毒相关的心脏病理学越来越多地被认识到。 HIV相关性心肌病是慢性HIV感染最常见的心脏特异性表现之一,在6-12%死于AIDS的患者中观察到。 然而,心血管受累已不仅仅是一种病理学上的好奇心,而是一个重要的发病原因,因为艾滋病毒感染者的寿命更长,生活更有成效。 HAART治疗的使用越来越多,有助于揭示HIV相关的心脏受累倾向。 尽管认识有所增加,但HIV相关心脏病的危险因素、发病机制和所需的具体治疗仍然未知。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Richard P Shannon其他文献
The Effect of a Teaching Hospital's Financial Crisis and Reorganization on a Group of Residents
教学医院的财务危机和重组对住院医师群体的影响
- DOI:
10.1097/00001888-200301000-00010 - 发表时间:
2003 - 期刊:
- 影响因子:0
- 作者:
Sharon C. Kiely;Kelly Russo;E. Orav;K. McMahon;Richard P Shannon;W. O'Donnell - 通讯作者:
W. O'Donnell
Why Patients Of Low Socioeconomic Status Prefer Hospitals Over and
为什么社会经济地位较低的患者更喜欢去医院
- DOI:
- 发表时间:
2013 - 期刊:
- 影响因子:0
- 作者:
D. Grande;S. Kangovi;F. Barg;Tamala Carter;Judith A. Long;Richard P Shannon - 通讯作者:
Richard P Shannon
Incorporating Acute Conditions into Risk-Adjustment for Provider Profiling: The Case of the US News and World Report Best Hospitals Rankings Methodology
将急性病症纳入提供者分析的风险调整中:以《美国新闻与世界报道》最佳医院排名方法论为例
- DOI:
10.1097/jmq.0000000000000171 - 发表时间:
2024 - 期刊:
- 影响因子:1.4
- 作者:
B. Hammill;Molly N. Hoffman;Amy G Clark;Jonathan G Bae;Richard P Shannon;Lesley H. Curtis - 通讯作者:
Lesley H. Curtis
Richard P Shannon的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Richard P Shannon', 18)}}的其他基金
SIV CARDIOMYOPATHY: PATHOGENESIS AND PREVENTION
SIV 心肌病:发病机制和预防
- 批准号:
8172808 - 财政年份:2010
- 资助金额:
$ 23.79万 - 项目类别:
SIV CARDIOMYOPATHY: PATHOGENESIS AND PREVENTION
SIV 心肌病:发病机制和预防
- 批准号:
7958300 - 财政年份:2009
- 资助金额:
$ 23.79万 - 项目类别:
SIV CARDIOMYOPATHY: PATHOGENESIS AND PREVENTION
SIV 心肌病:发病机制和预防
- 批准号:
7562005 - 财政年份:2007
- 资助金额:
$ 23.79万 - 项目类别:
SIV CARDIOMYOPATHY: PATHOGENESIS AND PREVENTION
SIV 心肌病:发病机制和预防
- 批准号:
7349494 - 财政年份:2006
- 资助金额:
$ 23.79万 - 项目类别:
Aging, Insulin Resistance, and Dilated Cardiomyopathy
衰老、胰岛素抵抗和扩张型心肌病
- 批准号:
7190036 - 财政年份:2004
- 资助金额:
$ 23.79万 - 项目类别:
Aging, Insulin Resistance, and Dilated Cardiomyopathy
衰老、胰岛素抵抗和扩张型心肌病
- 批准号:
6841640 - 财政年份:2004
- 资助金额:
$ 23.79万 - 项目类别:
Aging, Insulin Resistance, and Dilated Cardiomyopathy
衰老、胰岛素抵抗和扩张型心肌病
- 批准号:
7002279 - 财政年份:2004
- 资助金额:
$ 23.79万 - 项目类别:
Aging, Insulin Resistance, and Dilated Cardiomyopathy
衰老、胰岛素抵抗和扩张型心肌病
- 批准号:
7477691 - 财政年份:2004
- 资助金额:
$ 23.79万 - 项目类别:
相似海外基金
Examining the Function of a Novel Protein in the Cardiac Junctional Membrane Complex
检查心脏连接膜复合体中新型蛋白质的功能
- 批准号:
10749672 - 财政年份:2024
- 资助金额:
$ 23.79万 - 项目类别:
Towards widespread use of cardiac MRI using new affordable low magnetic field (0.55T) MRI scanner and AI
使用新型经济实惠的低磁场 (0.55T) MRI 扫描仪和 AI 实现心脏 MRI 的广泛使用
- 批准号:
2904562 - 财政年份:2024
- 资助金额:
$ 23.79万 - 项目类别:
Studentship
Targeting soluble guanylate cyclase as a novel strategy to treat and prevent cardiac arrhythmias: efficacy and mechanisms
靶向可溶性鸟苷酸环化酶作为治疗和预防心律失常的新策略:功效和机制
- 批准号:
MR/Y003594/1 - 财政年份:2024
- 资助金额:
$ 23.79万 - 项目类别:
Research Grant
Using Novel Machine Learning Methods to Personalize Strategies for Prevention of Persistent AKI after Cardiac Surgery
使用新颖的机器学习方法制定个性化策略,预防心脏手术后持续性 AKI
- 批准号:
10979324 - 财政年份:2024
- 资助金额:
$ 23.79万 - 项目类别:
Investigating the mechanosensitive interplays between genetic control and self-organisation during the emergence of cardiac tissue curvature
研究心脏组织曲率出现过程中遗传控制和自组织之间的机械敏感性相互作用
- 批准号:
BB/Y00566X/1 - 财政年份:2024
- 资助金额:
$ 23.79万 - 项目类别:
Research Grant
Novel minimally-invasive in-situ 3D bioprinting platform for cardiac regeneration
用于心脏再生的新型微创原位3D生物打印平台
- 批准号:
EP/X027287/2 - 财政年份:2024
- 资助金额:
$ 23.79万 - 项目类别:
Fellowship
Prevention of Infections in Cardiac Surgery (PICS): a cluster-randomized factorial cross-over trial
心脏手术中感染的预防 (PICS):整群随机因子交叉试验
- 批准号:
498291 - 财政年份:2023
- 资助金额:
$ 23.79万 - 项目类别:
Operating Grants
Postoperative reduction in thrombin generation in cardiac surgery: pathogenesis and evaluation
心脏手术术后凝血酶生成减少:发病机制和评估
- 批准号:
23H03001 - 财政年份:2023
- 资助金额:
$ 23.79万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of a novel therapy for cardiac fibrosis using a cell removal vaccine
使用细胞去除疫苗开发治疗心脏纤维化的新疗法
- 批准号:
23K07504 - 财政年份:2023
- 资助金额:
$ 23.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Aging of cardiac fibroblasts and heart failure: novel heart failure treatment through regeneration and transplantation of cardiac fibroblasts
心脏成纤维细胞的衰老和心力衰竭:通过心脏成纤维细胞的再生和移植治疗心力衰竭
- 批准号:
23K07526 - 财政年份:2023
- 资助金额:
$ 23.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




